Flynn James E 13D and 13G filings for Singular Genomics Systems, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-25 9:18 pm Sale |
2025-02-21 | 13D | Singular Genomics Systems, Inc. OMIC |
Flynn James E | 1,000 100.000% |
-248,495 (-99.60%) |
Filing |
| 2024-12-26 8:55 pm Unchanged |
2024-12-22 | 13D | Singular Genomics Systems, Inc. OMIC |
Flynn James E | 249,495 6.620% |
0 (Unchanged) |
Filing |
| 2024-11-01 7:54 pm Unchanged |
2024-10-31 | 13D | Singular Genomics Systems, Inc. OMIC |
Flynn James E | 249,495 6.660% |
0 (Unchanged) |
Filing |
| 2024-09-12 4:07 pm Purchase |
2024-09-05 | 13D | Singular Genomics Systems, Inc. OMIC |
Flynn James E | 249,495 6.660% |
249,495 (New Position) |
Filing |